COVID-19 Impact on Global Chronic Kidney Disease Drugs, Market Insights and Forecast to 2026
- BMR3903745
- 119 Pages
- June 2020
- Healthcare
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Chronic Kidney Disease Drugs industry.
Based on our recent survey, we have several different scenarios about the Chronic Kidney Disease Drugs YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 11010 million in 2019. The market size of Chronic Kidney Disease Drugs will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Chronic Kidney Disease Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Chronic Kidney Disease Drugs market in terms of both revenue and volume.
Players, stakeholders, and other participants in the global Chronic Kidney Disease Drugs market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Sales and Pricing Analyses
Readers are provided with deeper sales analysis and pricing analysis for the global Chronic Kidney Disease Drugs market. As part of sales analysis, the report offers accurate statistics and figures for sales and revenue by region, by each type segment for the period 2015-2026.
In the pricing analysis section of the report, readers are provided with validated statistics and figures for the price by players and price by region for the period 2015-2020 and price by each type segment for the period 2015-2020.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Chronic Kidney Disease Drugs market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of sales for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Chronic Kidney Disease Drugs market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Chronic Kidney Disease Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Chronic Kidney Disease Drugs market.
The following manufacturers are covered in this report:
Keryx Biopharmaceuticals, Inc
Kissei Pharmaceutical Co., Ltd
AbbVie
GlaxoSmithKline
Sanofi
F. Hoffmann-La Roche Ltd
Pfizer
AstraZeneca
Amgen
Teva Pharmaceutical Industries
Chronic Kidney Disease Drugs Breakdown Data by Type
ACE Inhibitors
Calcium Channel Blockers
Beta Blockers
Others
Chronic Kidney Disease Drugs Breakdown Data by Application
Hospitals
Specialty Clinics
1.1 Chronic Kidney Disease Drugs Product Introduction
1.2 Market Segments
1.3 Key Chronic Kidney Disease Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Chronic Kidney Disease Drugs Market Size Growth Rate by Type
1.4.2 ACE Inhibitors
1.4.3 Calcium Channel Blockers
1.4.4 Beta Blockers
1.4.5 Others
1.5 Market by Application
1.5.1 Global Chronic Kidney Disease Drugs Market Size Growth Rate by Application
1.5.2 Hospitals
1.5.3 Specialty Clinics
1.6 Coronavirus Disease 2019 (Covid-19): Chronic Kidney Disease Drugs Industry Impact
1.6.1 How the Covid-19 is Affecting the Chronic Kidney Disease Drugs Industry
1.6.1.1 Chronic Kidney Disease Drugs Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Chronic Kidney Disease Drugs Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Chronic Kidney Disease Drugs Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Executive Summary
2.1 Global Chronic Kidney Disease Drugs Market Size Estimates and Forecasts
2.1.1 Global Chronic Kidney Disease Drugs Revenue 2015-2026
2.1.2 Global Chronic Kidney Disease Drugs Sales 2015-2026
2.2 Chronic Kidney Disease Drugs Market Size by Region: 2020 Versus 2026
2.2.1 Global Chronic Kidney Disease Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Chronic Kidney Disease Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Chronic Kidney Disease Drugs Competitor Landscape by Players
3.1 Chronic Kidney Disease Drugs Sales by Manufacturers
3.1.1 Chronic Kidney Disease Drugs Sales by Manufacturers (2015-2020)
3.1.2 Chronic Kidney Disease Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Chronic Kidney Disease Drugs Revenue by Manufacturers
3.2.1 Chronic Kidney Disease Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Chronic Kidney Disease Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Chronic Kidney Disease Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Chronic Kidney Disease Drugs Revenue in 2019
3.2.5 Global Chronic Kidney Disease Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Chronic Kidney Disease Drugs Price by Manufacturers
3.4 Chronic Kidney Disease Drugs Manufacturing Base Distribution, Product Types
3.4.1 Chronic Kidney Disease Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Chronic Kidney Disease Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Chronic Kidney Disease Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Chronic Kidney Disease Drugs Market Size by Type (2015-2020)
4.1.1 Global Chronic Kidney Disease Drugs Sales by Type (2015-2020)
4.1.2 Global Chronic Kidney Disease Drugs Revenue by Type (2015-2020)
4.1.3 Chronic Kidney Disease Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Chronic Kidney Disease Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Chronic Kidney Disease Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Chronic Kidney Disease Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Chronic Kidney Disease Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Chronic Kidney Disease Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
5.1 Global Chronic Kidney Disease Drugs Market Size by Application (2015-2020)
5.1.1 Global Chronic Kidney Disease Drugs Sales by Application (2015-2020)
5.1.2 Global Chronic Kidney Disease Drugs Revenue by Application (2015-2020)
5.1.3 Chronic Kidney Disease Drugs Price by Application (2015-2020)
5.2 Chronic Kidney Disease Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Chronic Kidney Disease Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Chronic Kidney Disease Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Chronic Kidney Disease Drugs Price Forecast by Application (2021-2026)
6 North America
6.1 North America Chronic Kidney Disease Drugs by Country
6.1.1 North America Chronic Kidney Disease Drugs Sales by Country
6.1.2 North America Chronic Kidney Disease Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Chronic Kidney Disease Drugs Market Facts & Figures by Type
6.3 North America Chronic Kidney Disease Drugs Market Facts & Figures by Application
7 Europe
7.1 Europe Chronic Kidney Disease Drugs by Country
7.1.1 Europe Chronic Kidney Disease Drugs Sales by Country
7.1.2 Europe Chronic Kidney Disease Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Chronic Kidney Disease Drugs Market Facts & Figures by Type
7.3 Europe Chronic Kidney Disease Drugs Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Chronic Kidney Disease Drugs by Region
8.1.1 Asia Pacific Chronic Kidney Disease Drugs Sales by Region
8.1.2 Asia Pacific Chronic Kidney Disease Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Chronic Kidney Disease Drugs Market Facts & Figures by Type
8.3 Asia Pacific Chronic Kidney Disease Drugs Market Facts & Figures by Application
9 Latin America
9.1 Latin America Chronic Kidney Disease Drugs by Country
9.1.1 Latin America Chronic Kidney Disease Drugs Sales by Country
9.1.2 Latin America Chronic Kidney Disease Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Chronic Kidney Disease Drugs Market Facts & Figures by Type
9.3 Central & South America Chronic Kidney Disease Drugs Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Chronic Kidney Disease Drugs by Country
10.1.1 Middle East and Africa Chronic Kidney Disease Drugs Sales by Country
10.1.2 Middle East and Africa Chronic Kidney Disease Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Chronic Kidney Disease Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Chronic Kidney Disease Drugs Market Facts & Figures by Application
11 Company Profiles
11.1 Keryx Biopharmaceuticals, Inc
11.1.1 Keryx Biopharmaceuticals, Inc Corporation Information
11.1.2 Keryx Biopharmaceuticals, Inc Description, Business Overview and Total Revenue
11.1.3 Keryx Biopharmaceuticals, Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Keryx Biopharmaceuticals, Inc Chronic Kidney Disease Drugs Products Offered
11.1.5 Keryx Biopharmaceuticals, Inc Recent Development
11.2 Kissei Pharmaceutical Co., Ltd
11.2.1 Kissei Pharmaceutical Co., Ltd Corporation Information
11.2.2 Kissei Pharmaceutical Co., Ltd Description, Business Overview and Total Revenue
11.2.3 Kissei Pharmaceutical Co., Ltd Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Kissei Pharmaceutical Co., Ltd Chronic Kidney Disease Drugs Products Offered
11.2.5 Kissei Pharmaceutical Co., Ltd Recent Development
11.3 AbbVie
11.3.1 AbbVie Corporation Information
11.3.2 AbbVie Description, Business Overview and Total Revenue
11.3.3 AbbVie Sales, Revenue and Gross Margin (2015-2020)
11.3.4 AbbVie Chronic Kidney Disease Drugs Products Offered
11.3.5 AbbVie Recent Development
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Corporation Information
11.4.2 GlaxoSmithKline Description, Business Overview and Total Revenue
11.4.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.4.4 GlaxoSmithKline Chronic Kidney Disease Drugs Products Offered
11.4.5 GlaxoSmithKline Recent Development
11.5 Sanofi
11.5.1 Sanofi Corporation Information
11.5.2 Sanofi Description, Business Overview and Total Revenue
11.5.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Sanofi Chronic Kidney Disease Drugs Products Offered
11.5.5 Sanofi Recent Development
11.6 F. Hoffmann-La Roche Ltd
11.6.1 F. Hoffmann-La Roche Ltd Corporation Information
11.6.2 F. Hoffmann-La Roche Ltd Description, Business Overview and Total Revenue
11.6.3 F. Hoffmann-La Roche Ltd Sales, Revenue and Gross Margin (2015-2020)
11.6.4 F. Hoffmann-La Roche Ltd Chronic Kidney Disease Drugs Products Offered
11.6.5 F. Hoffmann-La Roche Ltd Recent Development
11.7 Pfizer
11.7.1 Pfizer Corporation Information
11.7.2 Pfizer Description, Business Overview and Total Revenue
11.7.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Pfizer Chronic Kidney Disease Drugs Products Offered
11.7.5 Pfizer Recent Development
11.8 AstraZeneca
11.8.1 AstraZeneca Corporation Information
11.8.2 AstraZeneca Description, Business Overview and Total Revenue
11.8.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.8.4 AstraZeneca Chronic Kidney Disease Drugs Products Offered
11.8.5 AstraZeneca Recent Development
11.9 Amgen
11.9.1 Amgen Corporation Information
11.9.2 Amgen Description, Business Overview and Total Revenue
11.9.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Amgen Chronic Kidney Disease Drugs Products Offered
11.9.5 Amgen Recent Development
11.10 Teva Pharmaceutical Industries
11.10.1 Teva Pharmaceutical Industries Corporation Information
11.10.2 Teva Pharmaceutical Industries Description, Business Overview and Total Revenue
11.10.3 Teva Pharmaceutical Industries Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Teva Pharmaceutical Industries Chronic Kidney Disease Drugs Products Offered
11.10.5 Teva Pharmaceutical Industries Recent Development
11.1 Keryx Biopharmaceuticals, Inc
11.1.1 Keryx Biopharmaceuticals, Inc Corporation Information
11.1.2 Keryx Biopharmaceuticals, Inc Description, Business Overview and Total Revenue
11.1.3 Keryx Biopharmaceuticals, Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Keryx Biopharmaceuticals, Inc Chronic Kidney Disease Drugs Products Offered
11.1.5 Keryx Biopharmaceuticals, Inc Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Chronic Kidney Disease Drugs Market Estimates and Projections by Region
12.1.1 Global Chronic Kidney Disease Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Chronic Kidney Disease Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Chronic Kidney Disease Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Chronic Kidney Disease Drugs Sales Forecast (2021-2026)
12.2.2 North America: Chronic Kidney Disease Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Chronic Kidney Disease Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Chronic Kidney Disease Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Chronic Kidney Disease Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Chronic Kidney Disease Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Chronic Kidney Disease Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Chronic Kidney Disease Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Chronic Kidney Disease Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Chronic Kidney Disease Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Chronic Kidney Disease Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Chronic Kidney Disease Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Chronic Kidney Disease Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Chronic Kidney Disease Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Chronic Kidney Disease Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Chronic Kidney Disease Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Chronic Kidney Disease Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Chronic Kidney Disease Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Chronic Kidney Disease Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Chronic Kidney Disease Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Chronic Kidney Disease Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
Table 1. Chronic Kidney Disease Drugs Market Segments
Table 2. Ranking of Global Top Chronic Kidney Disease Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Chronic Kidney Disease Drugs Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of ACE Inhibitors
Table 5. Major Manufacturers of Calcium Channel Blockers
Table 6. Major Manufacturers of Beta Blockers
Table 7. Major Manufacturers of Others
Table 8. COVID-19 Impact Global Market: (Four Chronic Kidney Disease Drugs Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Chronic Kidney Disease Drugs Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Chronic Kidney Disease Drugs Players to Combat Covid-19 Impact
Table 13. Global Chronic Kidney Disease Drugs Market Size Growth Rate by Application 2020-2026 (K MT)
Table 14. Global Chronic Kidney Disease Drugs Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 15. Global Chronic Kidney Disease Drugs Sales by Regions 2015-2020 (K MT)
Table 16. Global Chronic Kidney Disease Drugs Sales Market Share by Regions (2015-2020)
Table 17. Global Chronic Kidney Disease Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 18. Global Chronic Kidney Disease Drugs Sales by Manufacturers (2015-2020) (K MT)
Table 19. Global Chronic Kidney Disease Drugs Sales Share by Manufacturers (2015-2020)
Table 20. Global Chronic Kidney Disease Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 21. Global Chronic Kidney Disease Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chronic Kidney Disease Drugs as of 2019)
Table 22. Chronic Kidney Disease Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 23. Chronic Kidney Disease Drugs Revenue Share by Manufacturers (2015-2020)
Table 24. Key Manufacturers Chronic Kidney Disease Drugs Price (2015-2020) (USD/MT)
Table 25. Chronic Kidney Disease Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 26. Manufacturers Chronic Kidney Disease Drugs Product Type
Table 27. Date of International Manufacturers Enter into Chronic Kidney Disease Drugs Market
Table 28. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 29. Global Chronic Kidney Disease Drugs Sales by Type (2015-2020) (K MT)
Table 30. Global Chronic Kidney Disease Drugs Sales Share by Type (2015-2020)
Table 31. Global Chronic Kidney Disease Drugs Revenue by Type (2015-2020) (US$ Million)
Table 32. Global Chronic Kidney Disease Drugs Revenue Share by Type (2015-2020)
Table 33. Chronic Kidney Disease Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 34. Global Chronic Kidney Disease Drugs Sales by Application (2015-2020) (K MT)
Table 35. Global Chronic Kidney Disease Drugs Sales Share by Application (2015-2020)
Table 36. North America Chronic Kidney Disease Drugs Sales by Country (2015-2020) (K MT)
Table 37. North America Chronic Kidney Disease Drugs Sales Market Share by Country (2015-2020)
Table 38. North America Chronic Kidney Disease Drugs Revenue by Country (2015-2020) (US$ Million)
Table 39. North America Chronic Kidney Disease Drugs Revenue Market Share by Country (2015-2020)
Table 40. North America Chronic Kidney Disease Drugs Sales by Type (2015-2020) (K MT)
Table 41. North America Chronic Kidney Disease Drugs Sales Market Share by Type (2015-2020)
Table 42. North America Chronic Kidney Disease Drugs Sales by Application (2015-2020) (K MT)
Table 43. North America Chronic Kidney Disease Drugs Sales Market Share by Application (2015-2020)
Table 44. Europe Chronic Kidney Disease Drugs Sales by Country (2015-2020) (K MT)
Table 45. Europe Chronic Kidney Disease Drugs Sales Market Share by Country (2015-2020)
Table 46. Europe Chronic Kidney Disease Drugs Revenue by Country (2015-2020) (US$ Million)
Table 47. Europe Chronic Kidney Disease Drugs Revenue Market Share by Country (2015-2020)
Table 48. Europe Chronic Kidney Disease Drugs Sales by Type (2015-2020) (K MT)
Table 49. Europe Chronic Kidney Disease Drugs Sales Market Share by Type (2015-2020)
Table 50. Europe Chronic Kidney Disease Drugs Sales by Application (2015-2020) (K MT)
Table 51. Europe Chronic Kidney Disease Drugs Sales Market Share by Application (2015-2020)
Table 52. Asia Pacific Chronic Kidney Disease Drugs Sales by Region (2015-2020) (K MT)
Table 53. Asia Pacific Chronic Kidney Disease Drugs Sales Market Share by Region (2015-2020)
Table 54. Asia Pacific Chronic Kidney Disease Drugs Revenue by Region (2015-2020) (US$ Million)
Table 55. Asia Pacific Chronic Kidney Disease Drugs Revenue Market Share by Region (2015-2020)
Table 56. Asia Pacific Chronic Kidney Disease Drugs Sales by Type (2015-2020) (K MT)
Table 57. Asia Pacific Chronic Kidney Disease Drugs Sales Market Share by Type (2015-2020)
Table 58. Asia Pacific Chronic Kidney Disease Drugs Sales by Application (2015-2020) (K MT)
Table 59. Asia Pacific Chronic Kidney Disease Drugs Sales Market Share by Application (2015-2020)
Table 60. Latin America Chronic Kidney Disease Drugs Sales by Country (2015-2020) (K MT)
Table 61. Latin America Chronic Kidney Disease Drugs Sales Market Share by Country (2015-2020)
Table 62. Latin Americaa Chronic Kidney Disease Drugs Revenue by Country (2015-2020) (US$ Million)
Table 63. Latin America Chronic Kidney Disease Drugs Revenue Market Share by Country (2015-2020)
Table 64. Latin America Chronic Kidney Disease Drugs Sales by Type (2015-2020) (K MT)
Table 65. Latin America Chronic Kidney Disease Drugs Sales Market Share by Type (2015-2020)
Table 66. Latin America Chronic Kidney Disease Drugs Sales by Application (2015-2020) (K MT)
Table 67. Latin America Chronic Kidney Disease Drugs Sales Market Share by Application (2015-2020)
Table 68. Middle East and Africa Chronic Kidney Disease Drugs Sales by Country (2015-2020) (K MT)
Table 69. Middle East and Africa Chronic Kidney Disease Drugs Sales Market Share by Country (2015-2020)
Table 70. Middle East and Africa Chronic Kidney Disease Drugs Revenue by Country (2015-2020) (US$ Million)
Table 71. Middle East and Africa Chronic Kidney Disease Drugs Revenue Market Share by Country (2015-2020)
Table 72. Middle East and Africa Chronic Kidney Disease Drugs Sales by Type (2015-2020) (K MT)
Table 73. Middle East and Africa Chronic Kidney Disease Drugs Sales Market Share by Type (2015-2020)
Table 74. Middle East and Africa Chronic Kidney Disease Drugs Sales by Application (2015-2020) (K MT)
Table 75. Middle East and Africa Chronic Kidney Disease Drugs Sales Market Share by Application (2015-2020)
Table 76. Keryx Biopharmaceuticals, Inc Corporation Information
Table 77. Keryx Biopharmaceuticals, Inc Description and Major Businesses
Table 78. Keryx Biopharmaceuticals, Inc Chronic Kidney Disease Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 79. Keryx Biopharmaceuticals, Inc Product
Table 80. Keryx Biopharmaceuticals, Inc Recent Development
Table 81. Kissei Pharmaceutical Co., Ltd Corporation Information
Table 82. Kissei Pharmaceutical Co., Ltd Description and Major Businesses
Table 83. Kissei Pharmaceutical Co., Ltd Chronic Kidney Disease Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 84. Kissei Pharmaceutical Co., Ltd Product
Table 85. Kissei Pharmaceutical Co., Ltd Recent Development
Table 86. AbbVie Corporation Information
Table 87. AbbVie Description and Major Businesses
Table 88. AbbVie Chronic Kidney Disease Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 89. AbbVie Product
Table 90. AbbVie Recent Development
Table 91. GlaxoSmithKline Corporation Information
Table 92. GlaxoSmithKline Description and Major Businesses
Table 93. GlaxoSmithKline Chronic Kidney Disease Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 94. GlaxoSmithKline Product
Table 95. GlaxoSmithKline Recent Development
Table 96. Sanofi Corporation Information
Table 97. Sanofi Description and Major Businesses
Table 98. Sanofi Chronic Kidney Disease Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 99. Sanofi Product
Table 100. Sanofi Recent Development
Table 101. F. Hoffmann-La Roche Ltd Corporation Information
Table 102. F. Hoffmann-La Roche Ltd Description and Major Businesses
Table 103. F. Hoffmann-La Roche Ltd Chronic Kidney Disease Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 104. F. Hoffmann-La Roche Ltd Product
Table 105. F. Hoffmann-La Roche Ltd Recent Development
Table 106. Pfizer Corporation Information
Table 107. Pfizer Description and Major Businesses
Table 108. Pfizer Chronic Kidney Disease Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 109. Pfizer Product
Table 110. Pfizer Recent Development
Table 111. AstraZeneca Corporation Information
Table 112. AstraZeneca Description and Major Businesses
Table 113. AstraZeneca Chronic Kidney Disease Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 114. AstraZeneca Product
Table 115. AstraZeneca Recent Development
Table 116. Amgen Corporation Information
Table 117. Amgen Description and Major Businesses
Table 118. Amgen Chronic Kidney Disease Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 119. Amgen Product
Table 120. Amgen Recent Development
Table 121. Teva Pharmaceutical Industries Corporation Information
Table 122. Teva Pharmaceutical Industries Description and Major Businesses
Table 123. Teva Pharmaceutical Industries Chronic Kidney Disease Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 124. Teva Pharmaceutical Industries Product
Table 125. Teva Pharmaceutical Industries Recent Development
Table 126. Global Chronic Kidney Disease Drugs Sales Forecast by Regions (2021-2026) (K MT)
Table 127. Global Chronic Kidney Disease Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 128. Global Chronic Kidney Disease Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 129. Global Chronic Kidney Disease Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 130. North America: Chronic Kidney Disease Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 131. North America: Chronic Kidney Disease Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 132. Europe: Chronic Kidney Disease Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 133. Europe: Chronic Kidney Disease Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 134. Asia Pacific: Chronic Kidney Disease Drugs Sales Forecast by Region (2021-2026) (K MT)
Table 135. Asia Pacific: Chronic Kidney Disease Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 136. Latin America: Chronic Kidney Disease Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 137. Latin America: Chronic Kidney Disease Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 138. Middle East and Africa: Chronic Kidney Disease Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 139. Middle East and Africa: Chronic Kidney Disease Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 140. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 141. Key Challenges
Table 142. Market Risks
Table 143. Main Points Interviewed from Key Chronic Kidney Disease Drugs Players
Table 144. Chronic Kidney Disease Drugs Customers List
Table 145. Chronic Kidney Disease Drugs Distributors List
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
List of Figures
Figure 1. Chronic Kidney Disease Drugs Product Picture
Figure 2. Global Chronic Kidney Disease Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. ACE Inhibitors Product Picture
Figure 4. Calcium Channel Blockers Product Picture
Figure 5. Beta Blockers Product Picture
Figure 6. Others Product Picture
Figure 7. Global Chronic Kidney Disease Drugs Sales Market Share by Application in 2020 & 2026
Figure 8. Hospitals
Figure 9. Specialty Clinics
Figure 10. Chronic Kidney Disease Drugs Report Years Considered
Figure 11. Global Chronic Kidney Disease Drugs Market Size 2015-2026 (US$ Million)
Figure 12. Global Chronic Kidney Disease Drugs Sales 2015-2026 (K MT)
Figure 13. Global Chronic Kidney Disease Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Chronic Kidney Disease Drugs Sales Market Share by Region (2015-2020)
Figure 15. Global Chronic Kidney Disease Drugs Sales Market Share by Region in 2019
Figure 16. Global Chronic Kidney Disease Drugs Revenue Market Share by Region (2015-2020)
Figure 17. Global Chronic Kidney Disease Drugs Revenue Market Share by Region in 2019
Figure 18. Global Chronic Kidney Disease Drugs Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Chronic Kidney Disease Drugs Revenue in 2019
Figure 20. Chronic Kidney Disease Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Chronic Kidney Disease Drugs Sales Market Share by Type (2015-2020)
Figure 22. Global Chronic Kidney Disease Drugs Sales Market Share by Type in 2019
Figure 23. Global Chronic Kidney Disease Drugs Revenue Market Share by Type (2015-2020)
Figure 24. Global Chronic Kidney Disease Drugs Revenue Market Share by Type in 2019
Figure 25. Global Chronic Kidney Disease Drugs Market Share by Price Range (2015-2020)
Figure 26. Global Chronic Kidney Disease Drugs Sales Market Share by Application (2015-2020)
Figure 27. Global Chronic Kidney Disease Drugs Sales Market Share by Application in 2019
Figure 28. Global Chronic Kidney Disease Drugs Revenue Market Share by Application (2015-2020)
Figure 29. Global Chronic Kidney Disease Drugs Revenue Market Share by Application in 2019
Figure 30. North America Chronic Kidney Disease Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 31. North America Chronic Kidney Disease Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Chronic Kidney Disease Drugs Sales Market Share by Country in 2019
Figure 33. North America Chronic Kidney Disease Drugs Revenue Market Share by Country in 2019
Figure 34. U.S. Chronic Kidney Disease Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 35. U.S. Chronic Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Chronic Kidney Disease Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 37. Canada Chronic Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Chronic Kidney Disease Drugs Market Share by Type in 2019
Figure 39. North America Chronic Kidney Disease Drugs Market Share by Application in 2019
Figure 40. Europe Chronic Kidney Disease Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 41. Europe Chronic Kidney Disease Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Chronic Kidney Disease Drugs Sales Market Share by Country in 2019
Figure 43. Europe Chronic Kidney Disease Drugs Revenue Market Share by Country in 2019
Figure 44. Germany Chronic Kidney Disease Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 45. Germany Chronic Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Chronic Kidney Disease Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 47. France Chronic Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Chronic Kidney Disease Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 49. U.K. Chronic Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Chronic Kidney Disease Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 51. Italy Chronic Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Chronic Kidney Disease Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 53. Russia Chronic Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Chronic Kidney Disease Drugs Market Share by Type in 2019
Figure 55. Europe Chronic Kidney Disease Drugs Market Share by Application in 2019
Figure 56. Asia Pacific Chronic Kidney Disease Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 57. Asia Pacific Chronic Kidney Disease Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Chronic Kidney Disease Drugs Sales Market Share by Region in 2019
Figure 59. Asia Pacific Chronic Kidney Disease Drugs Revenue Market Share by Region in 2019
Figure 60. China Chronic Kidney Disease Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 61. China Chronic Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Chronic Kidney Disease Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 63. Japan Chronic Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Chronic Kidney Disease Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 65. South Korea Chronic Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Chronic Kidney Disease Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 67. India Chronic Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Chronic Kidney Disease Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 69. Australia Chronic Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Chronic Kidney Disease Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 71. Taiwan Chronic Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Chronic Kidney Disease Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 73. Indonesia Chronic Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Chronic Kidney Disease Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 75. Thailand Chronic Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Chronic Kidney Disease Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 77. Malaysia Chronic Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Chronic Kidney Disease Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 79. Philippines Chronic Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Chronic Kidney Disease Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 81. Vietnam Chronic Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Chronic Kidney Disease Drugs Market Share by Type in 2019
Figure 83. Asia Pacific Chronic Kidney Disease Drugs Market Share by Application in 2019
Figure 84. Latin America Chronic Kidney Disease Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 85. Latin America Chronic Kidney Disease Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Chronic Kidney Disease Drugs Sales Market Share by Country in 2019
Figure 87. Latin America Chronic Kidney Disease Drugs Revenue Market Share by Country in 2019
Figure 88. Mexico Chronic Kidney Disease Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 89. Mexico Chronic Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Chronic Kidney Disease Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 91. Brazil Chronic Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Chronic Kidney Disease Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 93. Argentina Chronic Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Chronic Kidney Disease Drugs Market Share by Type in 2019
Figure 95. Latin America Chronic Kidney Disease Drugs Market Share by Application in 2019
Figure 96. Middle East and Africa Chronic Kidney Disease Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 97. Middle East and Africa Chronic Kidney Disease Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Chronic Kidney Disease Drugs Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Chronic Kidney Disease Drugs Revenue Market Share by Country in 2019
Figure 100. Turkey Chronic Kidney Disease Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 101. Turkey Chronic Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Chronic Kidney Disease Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 103. Saudi Arabia Chronic Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Chronic Kidney Disease Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 105. U.A.E Chronic Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Chronic Kidney Disease Drugs Market Share by Type in 2019
Figure 107. Middle East and Africa Chronic Kidney Disease Drugs Market Share by Application in 2019
Figure 108. Keryx Biopharmaceuticals, Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Kissei Pharmaceutical Co., Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. F. Hoffmann-La Roche Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. Teva Pharmaceutical Industries Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. North America Chronic Kidney Disease Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 119. North America Chronic Kidney Disease Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Europe Chronic Kidney Disease Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 121. Europe Chronic Kidney Disease Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Asia Pacific Chronic Kidney Disease Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 123. Asia Pacific Chronic Kidney Disease Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 124. Latin America Chronic Kidney Disease Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 125. Latin America Chronic Kidney Disease Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 126. Middle East and Africa Chronic Kidney Disease Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 127. Middle East and Africa Chronic Kidney Disease Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 128. Porter's Five Forces Analysis
Figure 129. Channels of Distribution
Figure 130. Distributors Profiles
Figure 131. Bottom-up and Top-down Approaches for This Report
Figure 132. Data Triangulation
Figure 133. Key Executives Interviewed
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
